| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.089 | 0.05 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |